Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
110,211,131
-
Share change
-
-4,735,045
-
Total reported value
-
$1,975,638,827
-
Put/Call ratio
-
115%
-
Price per share
-
$17.93
-
Number of holders
-
284
-
Value change
-
-$82,796,616
-
Number of buys
-
103
-
Number of sells
-
130
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2020
As of 30 Jun 2020,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
284 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
110,211,131 shares.
The largest 10 holders included
GLENVIEW CAPITAL MANAGEMENT, LLC, PAULSON & CO. INC., Adelphi Capital LLP, RENAISSANCE TECHNOLOGIES LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, MACQUARIE GROUP LTD, NORTHERN TRUST CORP, Parametric Portfolio Associates LLC, and GMT CAPITAL CORP.
This page lists
288
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.